KLRK1 and esophageal squamous cell carcinoma: Besides, NKG2D CAR-T cells treatment could have a potential role in eradicating minimal residual disease and micrometastatic disease in ESCC patients, as CAR-T cells can survive and generate a population of long-lived central memory T cells for long-term immunological surveillance (38).